DeBay, Drew R.
Phi, Tân-Trào
Bowen, Chris V.
Burrell, Steven C.
Darvesh, Sultan
Funding for this research was provided by:
Faculty of Medicine, Dalhousie University (Collaborative Research Grant)
Mitacs (Accelerate Doctoral Internship Scholarship)
Research Nova Scotia (Scotia Scholar Award, Research Enterprise Development Initiatives – Catalyst Award)
Natural Sciences and Engineering Research Council of Canada
Killam Trusts
Dalhousie Medical Research Foundation (Gunn Family Research Prize)
Canadian Institutes of Health Research (PJT-153319)
Article History
Received: 6 April 2022
Accepted: 19 December 2022
First Online: 22 December 2022
Competing interests
: D.R.D., T.T.P., C.V.B. and S.C.B. declare no competing interests. S.D. is a scientific co-founder and stockholder in Treventis Corporation, a biotech company focused on development of diagnostic and therapeutic agents for Alzheimer’s disease and is listed as inventor on patents assigned to Treventis Corporation.